000 01032 a2200277 4500
005 20250516012849.0
264 0 _c20110412
008 201104s 0 0 eng d
022 _a1747-4094
024 7 _a10.1586/ehm.09.25
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGriesshammer, Martin
245 0 0 _aRole of platelet counts in the management of essential thrombocythemia: experience with anagrelide.
_h[electronic resource]
260 _bExpert review of hematology
_cJun 2009
300 _a227-36 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aBlood Platelets
_xdrug effects
650 0 4 _aHumans
650 0 4 _aPlatelet Aggregation Inhibitors
_xtherapeutic use
650 0 4 _aPlatelet Count
650 0 4 _aQuinazolines
_xtherapeutic use
650 0 4 _aRisk Factors
650 0 4 _aThrombocythemia, Essential
_xblood
773 0 _tExpert review of hematology
_gvol. 2
_gno. 3
_gp. 227-36
856 4 0 _uhttps://doi.org/10.1586/ehm.09.25
_zAvailable from publisher's website
999 _c20379762
_d20379762